Editorial: Lysosomal peptidases in tumor immunity

Front Immunol. 2023 Mar 14:14:1176736. doi: 10.3389/fimmu.2023.1176736. eCollection 2023.

Authors

Milica Perišić Nanut¹, Biljana Božić Nedeljković², Anahid Jewett³

Affiliations

¹ Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia.
² Institute for Physiology and Biochemistry "Ivan Djaja" Faculty of Biology, University of Belgrade, Belgrade, Serbia.
³ Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, University of California School of Dentistry, Los Angeles, CA, United States.

No abstract available

Keywords: T cell immunity; immunopeptidomics; immunotherapies; lysosomal peptidases; peptidase inhibitor.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Lysosomes / pathology
Neoplasms* / pathology
Peptide Hydrolases*

Substances

Peptide Hydrolases

Grants and funding

The external funding was from Slovenian Research Agency, grant J3-2516 (MPN).